세계의 부비동염 치료 시장 보고서(2025년)
Sinusitis Treatment Global Market Report 2025
상품코드 : 1825905
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,498,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,393,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,288,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

부비동염 치료 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 5.7%로 39억 2,000만 달러로 성장할 것입니다. 예측 기간의 성장은 부비동염 유병률 증가, 노인 인구 증가, 의료비 지출 증가, 알레르기 유병률 증가, 효율적인 치료 솔루션에 대한 수요 증가에 기인합니다. 예측 기간의 주요 동향으로는 부비동염 수술의 기술 발전, 비강 점안제 수요, 새로운 약물전달 기술 개발, 치료 옵션의 가용성, 기술 발전 등이 있습니다.

향후 5년간 5.7%의 성장률 전망은 지난번 예측보다 0.4% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 인상은 프랑스와 벨기에에서 조달하는 부신피질 스테로이드 비강주사제 및 풍선 부비동 성형술의 비용을 상승시키고, 본인 부담금을 악화시키고, 최소침습 수술에 대한 접근성을 제한함으로써 미국 환자들에게 부담을 줄 가능성이 높습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

천식과 같은 호흡기질환의 유병률 증가는 향후 몇 년 동안 부비동염 치료 시장의 성장을 촉진할 것으로 예상됩니다. 천식은 기도의 염증과 협착을 특징으로 하는 만성질환으로 천명, 호흡곤란, 흉부 압박감, 기침 등의 증상을 반복적으로 유발합니다. 천식 유병률의 증가는 환경오염, 알레르겐 노출, 유전적 요인, 도시화, 생활습관 변화, 호흡기 감염 등의 요인에 기인합니다. 부비동염 치료는 코 막힘을 제거하고 배액을 개선하여 비강내 점비약을 줄이고, 호흡기에 영향을 미치는 2차 감염의 위험을 최소화하는 데 중요한 역할을 합니다. 예를 들어, 2023년 11월 호주의 비영리 단체인 National Asthma Council은 2022년 천식 관련 사망자 수를 467명(여성 299명, 남성 168명)으로 보고했으며, 이는 2021년 사망자 수 355명보다 증가한 수치입니다. 이처럼 천식 유병률의 증가는 부비동염 치료 시장 확대에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Sinusitis treatment encompasses a spectrum of techniques and therapies aimed at mitigating its symptoms. As an inflammation or infection of the sinuses, sinusitis prompts the utilization of diverse treatment approaches, tailored to the severity and underlying cause of the condition, while also considering the individual's health status and medical history.

The primary treatment modalities for sinusitis include analgesics, antibiotics, antihistamines, surgery, corticosteroids, sulfonamides, and quinolones. Analgesics are medications formulated to alleviate pain without inducing unconsciousness. The various types of sinusitis include acute sinusitis, sub-acute sinusitis, and chronic sinusitis. These treatments are administered through various routes, including topical, nasal, oral, and injectable, and are typically available through online pharmacies, retail pharmacies, and hospital pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The sinusitis treatment market research report is one of a series of new reports from The Business Research Company that provides sinusitis treatment market statistics, including sinusitis treatment industry global market size, regional shares, competitors with a sinusitis treatment market share, detailed sinusitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the sinusitis treatment industry. This sinusitis treatment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sinusitis treatment market size has grown strongly in recent years. It will grow from $2.95 billion in 2024 to $3.13 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increased demand for diagnostic tests and antibiotics, increased use of generic drugs, health awareness, improved intra-nasal drug delivery, government support for healthcare programs and research.

The sinusitis treatment market size is expected to see strong growth in the next few years. It will grow to $3.92 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to rising prevalence rate of sinusitis, growing geriatric population, increasing healthcare expenditure, rising prevalence of allergies, growing need for efficient treatment solutions. Major trends in the forecast period include technological advancements in sinusitis surgery, demand for nasal sprays, development of new drug delivery technologies, availability of treatment options, advancements in technology.

The forecast of 5.7% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of corticosteroid nasal sprays and balloon sinuplasty devices sourced from France and Belgium, exacerbating out-of-pocket expenses and limiting access to minimally invasive procedures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of respiratory conditions like asthma is anticipated to drive the growth of the sinusitis treatment market in the coming years. Asthma is a chronic condition marked by inflammation and narrowing of the airways, causing recurrent symptoms such as wheezing, shortness of breath, chest tightness, and coughing. The increasing incidence of asthma is attributed to factors such as environmental pollution, allergen exposure, genetic factors, urbanization, lifestyle changes, and respiratory infections. Sinusitis treatments play a crucial role in clearing nasal blockages and improving drainage, thereby reducing postnasal drip and minimizing the risk of secondary infections that can impact the respiratory system. For example, in November 2023, the National Asthma Council, an Australian non-profit organization, reported 467 asthma-related deaths in 2022, including 299 females and 168 males, reflecting an increase from 355 deaths in 2021. Thus, the growing prevalence of asthma is contributing to the expansion of the sinusitis treatment market.

Key players in the sinusitis treatment market are innovating by developing new drugs such as steroid nasal sprays to enhance efficacy, minimize side effects, and provide more convenient dosing options. Steroid nasal sprays, known for their anti-inflammatory properties, are administered to address various nasal conditions. For example, Optinose Inc. introduced XHANCE in March 2024, an FDA-approved nasal spray utilizing the Exhalation Delivery System (EDS) to deliver topical steroids deep into the nasal cavity for effective treatment of chronic rhinosinusitis, with or without nasal polyps, in adults aged 18 and above.

In May 2022, Medtronic Plc acquired Intersect ENT for $1.1 billion, expanding its portfolio in sinusitis treatment. This acquisition enables Medtronic to leverage Intersect ENT's expertise in developing innovative products for sinus procedures, aimed at improving post-operative outcomes and treating nasal polyps. Intersect ENT's drug-delivery devices for ENT clinicians complement Medtronic's offerings, reinforcing its position in the sinusitis treatment market.

Major companies operating in the sinusitis treatment market are Johnson & Johnson, Pfizer Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Co., Medtronic Plc, GlaxoSmithKline Plc, Gilead Sciences Inc., Stryker Corp., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Fresenius Kabi AG, Olympus Corporation, Boehringer Ingelheim GmbH, Smith And Nephew Plc, Perrigo Company plc, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Cipla Ltd., Hikma Pharmaceuticals Plc, Apotex Inc., Lupin Pharmaceuticals Inc., Bionorica SE, Wockhardt Ltd., Zydus Cadila Ltd., Intersect ENT Inc.

North America was the largest region in the sinusitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sinusitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sinusitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sinusitis treatment market includes revenues earned by entities by diagnostic tests, medications, nasal irrigation and saline rinses, surgical treatments and related nasal drug delivery devices, acupressure, acupuncture, and facial massage. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sinusitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sinusitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for sinusitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sinusitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Sinusitis Treatment Market Characteristics

3. Sinusitis Treatment Market Trends And Strategies

4. Sinusitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sinusitis Treatment Growth Analysis And Strategic Analysis Framework

6. Sinusitis Treatment Market Segmentation

7. Sinusitis Treatment Market Regional And Country Analysis

8. Asia-Pacific Sinusitis Treatment Market

9. China Sinusitis Treatment Market

10. India Sinusitis Treatment Market

11. Japan Sinusitis Treatment Market

12. Australia Sinusitis Treatment Market

13. Indonesia Sinusitis Treatment Market

14. South Korea Sinusitis Treatment Market

15. Western Europe Sinusitis Treatment Market

16. UK Sinusitis Treatment Market

17. Germany Sinusitis Treatment Market

18. France Sinusitis Treatment Market

19. Italy Sinusitis Treatment Market

20. Spain Sinusitis Treatment Market

21. Eastern Europe Sinusitis Treatment Market

22. Russia Sinusitis Treatment Market

23. North America Sinusitis Treatment Market

24. USA Sinusitis Treatment Market

25. Canada Sinusitis Treatment Market

26. South America Sinusitis Treatment Market

27. Brazil Sinusitis Treatment Market

28. Middle East Sinusitis Treatment Market

29. Africa Sinusitis Treatment Market

30. Sinusitis Treatment Market Competitive Landscape And Company Profiles

31. Sinusitis Treatment Market Other Major And Innovative Companies

32. Global Sinusitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sinusitis Treatment Market

34. Recent Developments In The Sinusitis Treatment Market

35. Sinusitis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기